Blood Screening Market 2027 By Technology, Product and Service, End User and Geography | The Insight Partners

Blood Screening Market to 2027 - Global Analysis and Forecasts By Technology (Nucleic Acid Test (NAT), Enzyme-Linked Immunosorbent Assay (ELISA), Western Blot Assay, Next-Generation Sequencing (NGS), Rapid Tests); Product and Service (Reagents and Kits, Instruments, Software and Services); End User (Hospitals, Blood Banks) and Geography

Report Code: TIPRE00006182 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION

Blood screening is a test, which is used to perform before blood donation to ensure that blood units are safe. Screening for some diseases are should be mandatory such as, HIV, hepatitis B, hepatitis C and syphilis. In addition, regular blood testing helps to prevent and treat conditions associated with hormone imbalances, including weight gain, erectile dysfunction, fatigue, bone loss, memory impairment and depressed mood.

MARKET DYNAMICS

The blood screening market is anticipated to grow in the forecast, owing to rising awareness regarding maintaining of safety of donated blood, increasing prevalence of infectious diseases, increase in health care expenditure, increasing adoption of nucleic acid testing and increasing awareness about health care. In addition, rising number of initiatives by various governments and government associations is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Global Blood Screening Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of blood screening market with detailed market segmentation by technology, product and service, end user and geography. The global blood screening market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading blood screening market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global blood screening market is segmented on the basis technology, product and end user. Based on technology, the market is segmented as, nucleic acid test (NAT), enzyme-linked immunosorbent assay (ELISA), western blot assay, next-generation sequencing (NGS) and rapid tests. The blood screening market is categorized based on product such as reagents & kits, instruments and software & services. Based on end user, the market is bifurcated into, hospitals and blood banks.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global blood screening market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The blood screening market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting blood screening market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the blood screening market in these regions.

MARKET PLAYERS

The reports cover key developments in the blood screening market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from blood screening market are anticipated to lucrative growth opportunities in the future with the rising demand for blood screening market in the global market. Below mentioned is the list of few companies engaged in the blood screening market.

The report also includes the profiles of key blood screening market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- BD
- Beckman Coulter, Inc.
- Thermo Fisher Scientific Inc.
- Siemens
- Bio-Rad Laboratories, Inc.
- Abbott
- F. Hoffmann-La Roche Ltd
- Grifols, S.A.
- bioMérieux SA
- Ortho Clinical Diagnostics

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Blood Screening Market - By Technology
1.3.2 Blood Screening Market - By Product and Service
1.3.3 Blood Screening Market - By End User
1.3.4 Blood Screening Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BLOOD SCREENING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BLOOD SCREENING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BLOOD SCREENING MARKET - GLOBAL MARKET ANALYSIS
6.1. BLOOD SCREENING - GLOBAL MARKET OVERVIEW
6.2. BLOOD SCREENING - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. BLOOD SCREENING MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. NUCLEIC ACID TEST (NAT)
7.3.1. Overview
7.3.2. Nucleic Acid Test (NAT) Market Forecast and Analysis
7.4. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
7.4.1. Overview
7.4.2. Enzyme-Linked Immunosorbent Assay (ELISA) Market Forecast and Analysis
7.4.3. Generation Market
7.4.3.1. Overview
7.4.3.2. Generation Market Forecast and Analysis
7.4.4. Platform Market
7.4.4.1. Overview
7.4.4.2. Platform Market Forecast and Analysis
7.5. WESTERN BLOT ASSAY
7.5.1. Overview
7.5.2. Western Blot Assay Market Forecast and Analysis
7.6. NEXT-GENERATION SEQUENCING (NGS)
7.6.1. Overview
7.6.2. Next-Generation Sequencing (NGS) Market Forecast and Analysis
7.7. RAPID TESTS
7.7.1. Overview
7.7.2. Rapid Tests Market Forecast and Analysis
8. BLOOD SCREENING MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT AND SERVICE
8.1. OVERVIEW
8.2. PRODUCT AND SERVICE MARKET FORECASTS AND ANALYSIS
8.3. REAGENTS AND KITS
8.3.1. Overview
8.3.2. Reagents and Kits Market Forecast and Analysis
8.3.3. NAT Reagents and Kits Market
8.3.3.1. Overview
8.3.3.2. NAT Reagents and Kits Market Forecast and Analysis
8.3.4. ELISA Reagents and Kits Market
8.3.4.1. Overview
8.3.4.2. ELISA Reagents and Kits Market Forecast and Analysis
8.3.5. Other Reagents Market
8.3.5.1. Overview
8.3.5.2. Other Reagents Market Forecast and Analysis
8.4. INSTRUMENTS
8.4.1. Overview
8.4.2. Instruments Market Forecast and Analysis
8.5. SOFTWARE AND SERVICES
8.5.1. Overview
8.5.2. Software and Services Market Forecast and Analysis
9. BLOOD SCREENING MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. BLOOD BANKS
9.4.1. Overview
9.4.2. Blood Banks Market Forecast and Analysis
10. BLOOD SCREENING MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Blood Screening Market Overview
10.1.2 North America Blood Screening Market Forecasts and Analysis
10.1.3 North America Blood Screening Market Forecasts and Analysis - By Technology
10.1.4 North America Blood Screening Market Forecasts and Analysis - By Product and Service
10.1.5 North America Blood Screening Market Forecasts and Analysis - By End User
10.1.6 North America Blood Screening Market Forecasts and Analysis - By Countries
10.1.6.1 United States Blood Screening Market
10.1.6.1.1 United States Blood Screening Market by Technology
10.1.6.1.2 United States Blood Screening Market by Product and Service
10.1.6.1.3 United States Blood Screening Market by End User
10.1.6.2 Canada Blood Screening Market
10.1.6.2.1 Canada Blood Screening Market by Technology
10.1.6.2.2 Canada Blood Screening Market by Product and Service
10.1.6.2.3 Canada Blood Screening Market by End User
10.1.6.3 Mexico Blood Screening Market
10.1.6.3.1 Mexico Blood Screening Market by Technology
10.1.6.3.2 Mexico Blood Screening Market by Product and Service
10.1.6.3.3 Mexico Blood Screening Market by End User
10.2. EUROPE
10.2.1 Europe Blood Screening Market Overview
10.2.2 Europe Blood Screening Market Forecasts and Analysis
10.2.3 Europe Blood Screening Market Forecasts and Analysis - By Technology
10.2.4 Europe Blood Screening Market Forecasts and Analysis - By Product and Service
10.2.5 Europe Blood Screening Market Forecasts and Analysis - By End User
10.2.6 Europe Blood Screening Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Blood Screening Market
10.2.6.1.1 Germany Blood Screening Market by Technology
10.2.6.1.2 Germany Blood Screening Market by Product and Service
10.2.6.1.3 Germany Blood Screening Market by End User
10.2.6.2 France Blood Screening Market
10.2.6.2.1 France Blood Screening Market by Technology
10.2.6.2.2 France Blood Screening Market by Product and Service
10.2.6.2.3 France Blood Screening Market by End User
10.2.6.3 Italy Blood Screening Market
10.2.6.3.1 Italy Blood Screening Market by Technology
10.2.6.3.2 Italy Blood Screening Market by Product and Service
10.2.6.3.3 Italy Blood Screening Market by End User
10.2.6.4 Spain Blood Screening Market
10.2.6.4.1 Spain Blood Screening Market by Technology
10.2.6.4.2 Spain Blood Screening Market by Product and Service
10.2.6.4.3 Spain Blood Screening Market by End User
10.2.6.5 United Kingdom Blood Screening Market
10.2.6.5.1 United Kingdom Blood Screening Market by Technology
10.2.6.5.2 United Kingdom Blood Screening Market by Product and Service
10.2.6.5.3 United Kingdom Blood Screening Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Blood Screening Market Overview
10.3.2 Asia-Pacific Blood Screening Market Forecasts and Analysis
10.3.3 Asia-Pacific Blood Screening Market Forecasts and Analysis - By Technology
10.3.4 Asia-Pacific Blood Screening Market Forecasts and Analysis - By Product and Service
10.3.5 Asia-Pacific Blood Screening Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Blood Screening Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Blood Screening Market
10.3.6.1.1 Australia Blood Screening Market by Technology
10.3.6.1.2 Australia Blood Screening Market by Product and Service
10.3.6.1.3 Australia Blood Screening Market by End User
10.3.6.2 China Blood Screening Market
10.3.6.2.1 China Blood Screening Market by Technology
10.3.6.2.2 China Blood Screening Market by Product and Service
10.3.6.2.3 China Blood Screening Market by End User
10.3.6.3 India Blood Screening Market
10.3.6.3.1 India Blood Screening Market by Technology
10.3.6.3.2 India Blood Screening Market by Product and Service
10.3.6.3.3 India Blood Screening Market by End User
10.3.6.4 Japan Blood Screening Market
10.3.6.4.1 Japan Blood Screening Market by Technology
10.3.6.4.2 Japan Blood Screening Market by Product and Service
10.3.6.4.3 Japan Blood Screening Market by End User
10.3.6.5 South Korea Blood Screening Market
10.3.6.5.1 South Korea Blood Screening Market by Technology
10.3.6.5.2 South Korea Blood Screening Market by Product and Service
10.3.6.5.3 South Korea Blood Screening Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Blood Screening Market Overview
10.4.2 Middle East and Africa Blood Screening Market Forecasts and Analysis
10.4.3 Middle East and Africa Blood Screening Market Forecasts and Analysis - By Technology
10.4.4 Middle East and Africa Blood Screening Market Forecasts and Analysis - By Product and Service
10.4.5 Middle East and Africa Blood Screening Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Blood Screening Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Blood Screening Market
10.4.6.1.1 South Africa Blood Screening Market by Technology
10.4.6.1.2 South Africa Blood Screening Market by Product and Service
10.4.6.1.3 South Africa Blood Screening Market by End User
10.4.6.2 Saudi Arabia Blood Screening Market
10.4.6.2.1 Saudi Arabia Blood Screening Market by Technology
10.4.6.2.2 Saudi Arabia Blood Screening Market by Product and Service
10.4.6.2.3 Saudi Arabia Blood Screening Market by End User
10.4.6.3 U.A.E Blood Screening Market
10.4.6.3.1 U.A.E Blood Screening Market by Technology
10.4.6.3.2 U.A.E Blood Screening Market by Product and Service
10.4.6.3.3 U.A.E Blood Screening Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Blood Screening Market Overview
10.5.2 South and Central America Blood Screening Market Forecasts and Analysis
10.5.3 South and Central America Blood Screening Market Forecasts and Analysis - By Technology
10.5.4 South and Central America Blood Screening Market Forecasts and Analysis - By Product and Service
10.5.5 South and Central America Blood Screening Market Forecasts and Analysis - By End User
10.5.6 South and Central America Blood Screening Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Blood Screening Market
10.5.6.1.1 Brazil Blood Screening Market by Technology
10.5.6.1.2 Brazil Blood Screening Market by Product and Service
10.5.6.1.3 Brazil Blood Screening Market by End User
10.5.6.2 Argentina Blood Screening Market
10.5.6.2.1 Argentina Blood Screening Market by Technology
10.5.6.2.2 Argentina Blood Screening Market by Product and Service
10.5.6.2.3 Argentina Blood Screening Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BLOOD SCREENING MARKET, KEY COMPANY PROFILES
12.1. BD
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BECKMAN COULTER, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. THERMO FISHER SCIENTIFIC INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. SIEMENS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BIO-RAD LABORATORIES, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ABBOTT
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. F. HOFFMANN-LA ROCHE LTD
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. GRIFOLS, S.A.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. BIOMéRIEUX SA
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ORTHO CLINICAL DIAGNOSTICS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. BD
2. Beckman Coulter, Inc.
3. Thermo Fisher Scientific Inc.
4. Siemens
5. Bio-Rad Laboratories, Inc.
6. Abbott
7. F. Hoffmann-La Roche Ltd
8. Grifols, S.A.
9. bioMérieux SA
10. Ortho Clinical Diagnostics